Brief: Starcoin Group Enters MoU For Strategic Cooperation With Huamei Haibo Biotechnology (Chongqing)
26/03/2026 01:32
March 26 (Reuters) - Starcoin Group Ltd 0399.HK: ENTERS MOU FOR STRATEGIC COOPERATION WITH HUAMEI HAIBO BIOTECHNOLOGY (CHONGQING) ON MARCH 25 PARTIES TO EXPLORE EQUITY INVESTMENT, ASSET RESTRUCTURING, WEB3.0 HEALTHCARE CHAIN, OTHERS Further company coverage: 0399.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Starcoin
See all newsBrief: Starcoin Group Says Trading In Shares Of Co Will Suspend From 6 May
Brief: Starcoin Enters Non-Binding Memorandum Of Understanding With Marvel Nice
Brief: Starcoin Group Enters MoU For Strategic Cooperation With Huamei Haibo Biotechnology (Chongqing)
Brief: Starcoin Group Says Unit, Others Enters Deal For Brazilian Gold Mine RWA Tokenization
Brief: Starcoin Group, Newbridge And Conflux Foundation Entered MoU